checkAd
    Startseite > Aktien > Nurix Therapeutics > Nachrichten
    Nurix Therapeutics Aktie
    16,190
     
    USD
    -2,41 %
    -0,400 USD
    Letzter Kurs 02:00:00 Nasdaq
    16,190
     
    USD
    5.900 STK
    Geldkurs 20.05.24
    16,220
     
    USD
    3.200 STK
    Briefkurs 20.05.24
    ISIN: US67080M1036 · WKN: A2P85Z · SYM: NRIX · USA

    Neueste Nachrichten

    Nurix Therapeutics Announces Board Chair Transition
    20.05.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)
    14.05.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
    07.05.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    17.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
    12.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Announces Proposed Public Offering
    11.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
    10.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies
    09.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
    09.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics to Participate in Upcoming Investor Conferences
    03.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
    02.04.24 · globenewswire · Nurix Therapeutics
    Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)
    25.03.24 · globenewswire · Nurix Therapeutics